Fourpath Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-124
Closed -$3.58K 258
2024
Q3
$3.58K Buy
+124
New +$3.58K ﹤0.01% 600